Westfield, NJ, United States of America

Zhiquang Yang

This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhiquang Yang. Retrieved from https://idiyas.com/inventor/zhiquang-yang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhiquang Yang: Innovator in Pharmaceutical Chemistry

Introduction

Zhiquang Yang is a notable inventor based in Westfield, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can modulate critical biological processes.

Latest Patents

Zhiquang Yang holds a patent for "Imidazo-pyrazine derivatives useful as soluble guanylate cyclase activators." This invention involves a compound of Formula II or a pharmaceutically acceptable salt thereof, which is capable of modulating the body's production of cyclic guanosine monophosphate (cGMP). These compounds are generally suitable for the therapy and prophylaxis of diseases associated with a disturbed cGMP balance. The patent also details processes for preparing these compounds and their use in pharmaceuticals.

Career Highlights

Zhiquang Yang is currently associated with Merck Sharp & Dohme Corporation, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic agents that can improve patient outcomes.

Collaborations

Some of his notable coworkers include Brian T Campbell and Guizhen Dong, who contribute to the collaborative efforts in research and development at Merck Sharp & Dohme Corporation.

Conclusion

Zhiquang Yang's contributions to pharmaceutical chemistry, particularly through his patent on Imidazo-pyrazine derivatives, highlight his role as an innovator in the field. His work continues to pave the way for advancements in therapies that address critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…